These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4005650)

  • 21. Patient tolerance study of topical chlorhexidine diphosphanilate: a new topical agent for burns.
    Miller LM; Loder JS; Hansbrough JF; Peterson HD; Monafo WW; Jordan MH
    Burns; 1990 Jun; 16(3):217-20. PubMed ID: 2383364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allergic contact dermatitis to silver in a patient treated with silver sulphadiazine after a burn.
    García AA; Rodríguez Martín AM; Serra Baldrich E; Manubens Mercade E; Puig Sanz L
    J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):365-6. PubMed ID: 25338976
    [No Abstract]   [Full Text] [Related]  

  • 23. A laboratory method to evaluate formulation effects on the in vitro antimicrobial activity of topical creams and ointments.
    Love D; Kubey W; Holmes CJ
    Burns Incl Therm Inj; 1987 Jun; 13(3):204-7. PubMed ID: 3300889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of silver sulfadiazine and gentamicin for topical prophylaxis against burn wound sepsis.
    Snelling CF; Ronald AR; Waters WR; Yaworski DS; Drulak K; Sunderland M
    Can Med Assoc J; 1978 Sep; 119(5):466-70. PubMed ID: 99223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silver sulfadiazine (AgSD) resistant pseudomonas infection in experimental burn wounds.
    Modak SM; Stanford JW; Bradshaw W; Fox CL
    Panminerva Med; 1983; 25(3):181-8. PubMed ID: 6669393
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of silver preparations in surgery and traumatology (review of foreign literature)].
    Savadian ESh
    Khirurgiia (Mosk); 1989 Aug; (8):135-9. PubMed ID: 2681943
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experimental study of the local application of silver sulfadiazine, cefsulodin and povidone-iodine in burns].
    Kaiser W; von der Lieth H; Potel J; Heymann H
    Infection; 1984; 12(1):31-5. PubMed ID: 6706410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The treatment of sepsis in superficial burns: effect of 1% Silver Sulphadiazine.
    Sharma BC; Wosornu L; Paonaskar V
    Med J Zambia; 1979; 13(2):35-40. PubMed ID: 263370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined use of topical cyclosporin A and silver sulphadiazine on allografts infected with Pseudomonas in burned rats.
    Lai CS; Miskell P; Gonce SJ; Alexander JW; Babcock GF
    Burns Incl Therm Inj; 1987 Jun; 13(3):181-4. PubMed ID: 3111646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The preparation and invivo use of silver sulphadiazine cream for treatment of burns infected with Pseudomonas aeruginosa.
    Drake DJ; Froese EH
    Cent Afr J Med; 1975 Apr; 21(4):71-2. PubMed ID: 806345
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibiotic prophylaxis and therapy in burns.
    Gillett AP
    J Hosp Infect; 1985 Sep; 6 Suppl B():59-66. PubMed ID: 2865312
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term experience with 1 per cent topical silver sulphadiazine cream in the management of burn wounds.
    Sawhney CP; Sharma RK; Rao KR; Kaushish R
    Burns; 1989 Dec; 15(6):403-6. PubMed ID: 2516445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of topical cerium nitrate-silver sulfadiazine in major burn injuries.
    Monafo L
    Panminerva Med; 1983; 25(3):151-4. PubMed ID: 6669387
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute leukopenia during topical burn therapy with silver sulfadiazine.
    Jarrett F; Ellerbe S; Demling R
    Am J Surg; 1978 Jun; 135(6):818-9. PubMed ID: 665909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukopenia in non-septic burn patients receiving topical 1% silver sulfadiazine cream therapy: a survey.
    Fuller FW; Engler PE
    J Burn Care Rehabil; 1988; 9(6):606-9. PubMed ID: 3220867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silver sulfadiazine-impregnated biologic membranes as burn wound covers.
    Modak S; Fox P; Stanford J; Sampath L; Fox CL
    J Burn Care Rehabil; 1986; 7(5):422-5. PubMed ID: 3639881
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of topical dimethyl sulfoxide in burn wound infection: evaluation in the rat.
    Raskin DJ; Sullivan KH; Rappaport NH
    Ann N Y Acad Sci; 1983; 411():105-9. PubMed ID: 6576686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo comparison of two silver sulfadiazine antimicrobial agents on burn wound infection.
    Velanovich V; Heggers JP; Robson MC; Zoellner SM; McHugh TP; Boertman J; Niu XT; Schileru R
    J Burn Care Rehabil; 1987; 8(5):381-3. PubMed ID: 3667664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical therapy for control of bacteria in the burn wound.
    Moncrief JA
    World J Surg; 1978 Mar; 2(2):151-65. PubMed ID: 676330
    [No Abstract]   [Full Text] [Related]  

  • 40. Topical silver sulphadiazine--a new drug for ocular keratomycosis.
    Mohan M; Gupta SK; Kalra VK; Vajpayee RB; Sachdev MS
    Br J Ophthalmol; 1988 Mar; 72(3):192-5. PubMed ID: 3281706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.